Skip to main content
TRVI logo

TRVI · Trevi Therapeutics, Inc. · Proposed Sales

Track TRVI — free
$13.35 -0.37 (-2.70%) At close · Nov 20 Play latest call Q3 2026 earnings call transcript
Market Cap
$1.90B
Shares
142.56M
Volume · Nov 20 2.09M Avg daily vol (3M) 1.99M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-09-15 MICHAEL HEFFERNAN 39,473
2025-10-07 Delfini Lisa 108,650
2025-10-03 Delfini Lisa 40,000
2025-08-27 Delfini Lisa 312,855
2025-03-21 GOOD JENNIFER L 5,263
2025-03-10 Simon Farrell 81,313
2024-09-03 GOOD JENNIFER L 61,180
2024-08-27 Meeker David P 4,555
2024-08-15 SCIASCIA THOMAS 48,001
2024-05-29 SCIASCIA THOMAS 53,368
2023-09-11 Delfini Lisa 1,600
2023-06-12 Delfini Lisa 1,615
2023-04-11 Delfini Lisa 1,900
Showing 1–13 of 13 filings
Key facts CIK 1563880 CUSIP 89532M101 13F (30d) 224 filings 210 filers Visit website Investor relations